Sunday, June 21, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,769
Drugs linked 4,797

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 1074 of 1,261

  1. US 7288263

    Compositions and methods for treatment of skin discoloration

    Evera Laboratories, LLC · Granted Oct 30, 2007 · Expires Oct 25, 2027

    granted

  2. US 7288254

    Use of immunotoxins to induce immune tolerance to pancreatic islet transplantation

    The United States of America as Represented by the Secretary Department of Health and Human Services (NIH) · Granted Oct 30, 2007 · Expires Oct 25, 2027

    granted

  3. US 7288654

    Fused-ring pyridine derivative, process for producing the same, and use

    Takeda Pharmaceutical Company Limited · Granted Oct 30, 2007 · Expires Oct 25, 2027

    granted

  4. US 7288671

    Interleukin-1 and tumor necrosis factor-α modulators, synthesis of said modulators and their enantiomers and methods of using said modulators

    The Regents of the University of California · Granted Oct 30, 2007 · Expires Oct 25, 2027

    granted

  5. US 7288624

    Inhibitors of interleukin-1β converting enzyme

    Vertex Pharmaceuticals Incorporated · Granted Oct 30, 2007 · Expires Oct 25, 2027

    granted

  6. EP 1847258

    Partialglyceride als Schmiermittel für pharmazeutische Zusammensetzungen enthaltend Thieno[3,2-c]pyridin-Derivate

    RENTSCHLER GMBH [DE] · Granted Oct 24, 2007 · Expires Oct 19, 2027

    granted

  7. US 7285668

    Process for the crystallization of (R)- or (S)-lansoprazole

    Takeda Pharmaceutical Company Limited · Granted Oct 23, 2007 · Expires Oct 18, 2027

    granted

  8. US 7285564

    Substituted 4-amino-1-(pyridylmethyl)piperidine and related compounds

    Theravance, Inc. · Granted Oct 23, 2007 · Expires Oct 18, 2027

    granted

  9. US 7285556

    Thienopyrimidine-based inhibitors of the src family

    The Board of Regents of the University of Texas System · Granted Oct 23, 2007 · Expires Oct 18, 2027

    granted

  10. US 7285534

    Corticotropin-releasing hormone analogs and their uses

    The Regents of the University of California · Granted Oct 23, 2007 · Expires Oct 18, 2027

    granted

  11. US 7285639

    Antibody to telomerase reverse transcriptase

    The Regents of the University of Colorado · Granted Oct 23, 2007 · Expires Oct 18, 2027

    granted

  12. US 7285527

    Tumor radiosensitization using gene therapy

    The Regents of the University of California · Granted Oct 23, 2007 · Expires Oct 18, 2027

    granted

  13. US 7285281

    Mutant forms of cholera holotoxin as an adjuvant

    The Regents of the University of Colorado, a Body Corporate · Granted Oct 23, 2007 · Expires Oct 18, 2027

    granted

  14. US 7285363

    Photoactivators, methods of use, and the articles derived therefrom

    UNIVERSITY OF CONNECTICUT · Granted Oct 23, 2007 · Expires Oct 18, 2027

    granted

  15. US 7285383

    Method for selective inactivation of viral replication

    Rigel Pharmaceuticals, Inc. · Granted Oct 23, 2007 · Expires Oct 18, 2027

    granted

  16. US 7285532

    Therapeutic method for treating bone formation diseases

    REGENERON PHARMACEUTICALS, INC. · Granted Oct 23, 2007 · Expires Oct 18, 2027

    granted

  17. US 7285683

    Bicyclic and tricyclic cannabinoids

    UNIVERSITY OF CONNECTICUT · Granted Oct 23, 2007 · Expires Oct 18, 2027

    granted

  18. US 7285415

    Oligodendrocytes derived from human embryonic stem cells for remyelination and treatment of spinal cord injury

    The Regents of the University of California · Granted Oct 23, 2007 · Expires Oct 18, 2027

    granted

  19. US 7285542

    Hyperthermic inducible expression vectors for gene therapy and methods of use thereof

    Arizona Board of Regents on Behalf of the University of Arizona · Granted Oct 23, 2007 · Expires Oct 18, 2027

    granted

  20. US 7282206

    Treatment of fibrosis by antagonism of IL-13 and IL-13 receptor chains

    The United States of America, as represented by the Department of Health and Human Services · Granted Oct 16, 2007 · Expires Oct 11, 2027

    granted

  21. US 7282482

    NGF for the prevention of demyelination in the nervous system

    The Regents of the University of California · Granted Oct 16, 2007 · Expires Oct 11, 2027

    granted

  22. US 7282205

    Anti-hepatitis A virus antibodies

    The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Oct 16, 2007 · Expires Oct 11, 2027

    granted

  23. US 7282563

    Opioid receptors and methods of use

    The Regents of the University of California · Granted Oct 16, 2007 · Expires Oct 11, 2027

    granted

  24. US 7279320

    Curlicue vaccine strain of Bacillus anthracis

    United States Army as Represented by the Secretary of the Army · Granted Oct 9, 2007 · Expires Oct 4, 2027

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.